Baird Medical Investment (BDMD) Stock Price, News & Analysis

Company Overview

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.

Key Stats

• Today's Range: $5.13 to $5.46
• 50-Day Range: $3.53 to $6.44
• 52-Week Range: $1.05 to $12.50
• Volume: 27,990 shs
• Average Volume: 545,116 shs
• Market Capitalization: $35.62 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BDMD Stock Analysis - Frequently Asked Questions

How have BDMD shares performed this year?

Baird Medical Investment's stock was trading at $7.60 at the beginning of the year. Since then, BDMD stock has decreased by 28.8% and is now trading at $5.41.
View the best growth stocks for 2025 here.

How do I buy shares of Baird Medical Investment?

Shares of BDMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Baird Medical Investment own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Baird Medical Investment investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

• Today: 4/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical, Medical, And Dental Instruments And Supplies
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:BDMD
• Previous Symbol: NASDAQ:BDMD
• CIK: 1982444
• Web: N/A
• Phone: 86 159 1316 5120
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $33.05 million
• Price / Sales: 1.08
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 6,584,000
• Free Float: 1,389,000
• Market Cap: $35.62 million
• Optionable: N/A
• Beta: -0.73